vaccines

Nanotech, immunotherapy combo vaccinates mouse against cancer
Nanotech, immunotherapy combo vaccinates mouse against cancer
Drug Delivery Business News
nanotech
immunotherapy
vaccines
cancer
Flag link:
Dynavax shares dip after FDA asks for more time to sort out Heplisav post-marketing plan
Dynavax shares dip after FDA asks for more time to sort out Heplisav post-marketing plan
Endpoints
Dynavax
FDA
Heplisav
vaccines
hepatitis B
Flag link:
Vaccines provide a boost for GlaxoSmithKline, Sanofi and Merck in second-quarter financials
Vaccines provide a boost for GlaxoSmithKline, Sanofi and Merck in second-quarter financials
Fierce Pharma
vaccines
GSK
Sanofi
Merck
earnings
Flag link:
Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel
Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel
Yahoo/Reuters
Dynavax
vaccines
hepatitis B
Heplisav
FDA
advisory panels
Flag link:
J&J inks $879M vaccine deal with Bavarian Nordic
J&J inks $879M vaccine deal with Bavarian Nordic
BioPharma Dive
JNJ
vaccines
Bavarian Nordic
Janssen
hepatitis B
Flag link:
Dynavax shares slide as FDA review spotlights a hazy safety issue for Heplisav
Dynavax shares slide as FDA review spotlights a hazy safety issue for Heplisav
Endpoints
Dynavax
FDA
Heplisav
hepatitis B
vaccines
Flag link:
Provention Bio wants to stop Type I diabetes – with a vaccine
Provention Bio wants to stop Type I diabetes – with a vaccine
Drug Delivery Business News
Provention Bio
type 1 diabetes
vaccines
Flag link:
Novavax makes a case for a do-over on its failed RSV vaccine — but it’s an uphill climb
Novavax makes a case for a do-over on its failed RSV vaccine — but it’s an uphill climb
Endpoints
Novavax
vaccines
RSV
RSV F vaccine
Flag link:
J&J touts first-in-human data for HIV vaccine
J&J touts first-in-human data for HIV vaccine
Drug Delivery Business News
JNJ
HIV
vaccines
Janssen
Flag link:
Merck’s Zostavax draws new litigation from patients alleging they contracted shingles
Merck’s Zostavax draws new litigation from patients alleging they contracted shingles
Fierce Pharma
Merck
Zostavax
vaccines
shingles
Flag link:
The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.
The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.
Fierce Pharma
GSK
Sanofi
vaccines
flu vaccines
Seqirus
Flag link:
Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report
Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report
Fierce Pharma
Takeda
R&D
drug reps
layoffs
reorganization
vaccines
Boston
Flag link:
VBI Vaccines takes a shot at HBV Phase 3
VBI Vaccines takes a shot at HBV Phase 3
BioPharma Dive
VBI Vaccines
vaccines
Sci-B-Vac
hepatitis B
Flag link:
HPV Infection Rates Plummet With Vaccination
HPV Infection Rates Plummet With Vaccination
Forbes
HPV
vaccines
cervical cancer
Gardasil
Merck
Flag link:
Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy
Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy
Fierce Pharma
Sanofi
Sanofi Pasteur
M&A
Protein Sciences
flu vaccine
vaccines
Flag link:
Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication
Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication
Fierce Pharma
Sanofi
Zika virus
vaccines
Department of Defense
Flag link:
Personalized cancer vaccines vanquish melanoma in small but encouraging study
Personalized cancer vaccines vanquish melanoma in small but encouraging study
Stat
personalized medicine
cancer
vaccines
melanoma
Keytruda
Merck
Neon Therapeutics
Flag link:
Pain-free microneedle patch could help boost flu vaccination rates
Pain-free microneedle patch could help boost flu vaccination rates
Fierce Pharma
vaccines
drug delivery
Micron Biomedical
Flag link:
Senators lay into Sanofi for Zika vaccine deal, call for public hearing
Senators lay into Sanofi for Zika vaccine deal, call for public hearing
Fierce Pharma
vaccines
Senate
Zika virus
Sanofi
Sanofi Pasteur
Flag link:
Eyeing a $6B market, Bavarian Nordic posts positive phase 2 data for universal RSV vaccine
Eyeing a $6B market, Bavarian Nordic posts positive phase 2 data for universal RSV vaccine
Fierce Pharma
Bavarian Nordic
clinical trials
vaccines
RSV
Flag link:

Pages